Nymox Pharmaceutical Corp Stock News

IRVINE, CA / ACCESS Newswire / June 17, 2026 / Nymox Pharmaceutical Corporation ("Nymox", "The Company") (OTCQB:NYMXF) is pleased to announce that it has entered into a formal agreement for its drug treatments for prostate conditions, with the Global Alliance of Regenerative Medicine (GARM) on Roatan Island in the Western Caribbean. Nymox's Nymozarfex (TM) which is owned and developed by Nymox,...

IRVINE, CA / ACCESS Newswire / June 2, 2026 / Nymox Pharmaceutical Corporation ("Nymox", "The Company") (OTCQB:NYMXF) reports that its plans for Nymozarfex (TM) are currently focused on re-submission in the US for marketing approval. The initial US submission was not accepted to be reviewed.